SHINPOONG PHARMACEUTICAL CO.,LTD Logo

SHINPOONG PHARMACEUTICAL CO.,LTD

Develops and manufactures pharmaceuticals, APIs, and medical devices for global markets.

019170 | KO

Overview

Corporate Details

ISIN(s):
KR7019170000
LEI:
Country:
South Korea
Address:
경기도 안산시 단원구 원시로 7, 안산시

Description

SHINPOONG PHARMACEUTICAL CO.,LTD. is a research and development-oriented pharmaceutical company that manufactures and markets a wide range of pharmaceutical products and active pharmaceutical ingredients (APIs). The company's portfolio includes finished products such as cephalosporin and penicillin antibiotics, antivirals, anticancer drugs, and painkillers. It also develops and supplies medical devices, including Medicurtain, an anti-adhesion barrier. The company manages the entire production process from raw materials to finished goods, serving both domestic and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-14 00:00
[기재정정]사업보고서 (2024.12)
Korean 2.1 MB
2025-06-27 00:00
투자판단관련주요경영사항 (유행성 RNA 바이러스 감염질환의 예방 또는 치료용 약제학적 조성물_국내특허취득)
Korean 7.4 KB
2025-06-16 00:00
투자판단관련주요경영사항 (유행성 RNA 바이러스 감염질환의 예방 또는 치료용 약제학적 조성물_특허취득)
Korean 7.5 KB
2025-05-30 00:00
불성실공시법인지정
Korean 7.2 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.7 MB
2025-05-15 00:00
[기재정정]분기보고서 (2025.03)
Korean 1.7 MB
2025-05-12 00:00
불성실공시법인지정예고
Korean 6.0 KB
2025-05-08 00:00
횡령ㆍ배임사실확인
Korean 9.5 KB
2025-04-03 00:00
투자판단관련주요경영사항 (골관절염 주사요법제 SP5M002주의 임상 3상 시험 Topline 결과 발표)
Korean 14.8 KB
2025-03-28 00:00
정기주주총회결과
Korean 18.7 KB
2025-03-20 00:00
[첨부추가]사업보고서 (2024.12)
Korean 2.1 MB
2025-03-19 00:00
감사보고서제출
Korean 20.9 KB
2025-03-07 00:00
주주총회소집결의
Korean 7.8 KB
2025-03-07 00:00
주주총회소집공고
Korean 144.2 KB

Automate Your Workflow. Get a real-time feed of all SHINPOONG PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SHINPOONG PHARMACEUTICAL CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SHINPOONG PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.